US FDA Panel Rejects Pfizer's Broad COVID Booster Plan But Backs Narrower Authorization For Third Vaccine Shot

Jaws of shark
A second, hastily written voting question on boosters allowed FDA leaders and the Biden Administration to snatch victory from the jaws of defeat. • Source: Alamy

More from US FDA Performance Tracker

More from Regulatory Trackers